MEDI-1912
MEDI-1912 is a human monoclonal antibody (mAb) targeting NGF/bNGF. MEDI-1912 inhibits signaling through TrkA and p75 receptors. MEDI-1912 can be used in chronic pain research[1].
Product Specifications
UNSPSC
12352203
Target
Neurokinin Receptor; Trk Receptor
Related Pathways
GPCR/G Protein; Neuronal Signaling; Protein Tyrosine Kinase/RTK
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
[MEDI-1912]
References & Citations
[1]Dobson CL, et al. Engineering the surface properties of a human monoclonal antibody prevents self-association and rapid clearance in vivo. Sci Rep. 2016 Dec 20;6:38644.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1183228-01 1 mg (E-Coli)
Recombinant Escherichia coli Inner membrane symporter yihP (yihP), partial
Ask
View Details